A comprehensive view of vaccination / immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna reports early progress in vaccines for Epstein-Barr virus, norovirus and shingles during its vaccines day; Moderna reports vaccine candidates show stronger immune responses and generally well-tolerated results in early clinical trials

Moderna initiates final phase of trials for four vaccines against latent infections, including chickenpox and shingles, and norovirus responsible for gastroenteritis; the company also developing a new-generation COVID-19 vaccine

IR Insights: Recapping our Fifth Annual Vaccines Day

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials

Moderna's next-generation COVID-19 vaccine, mRNA-1283, shows a higher immune response against SARS-CoV-2 in Phase 3 trial compared to the company's currently vaccine; the new vaccine also has potential for longer shelf life and storage benefits

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count